Roger Daltrey and Joan Jett in Concert for a Great Cause
Published on
Rock singers Roger Daltrey and Joan Jett will present an evening of music and philanthropy at Verizon Hall at the Kimmel Center in Philadelphia on July 28, 2014.
Cancer Center News and Updates
231 - 240 of 246
Taylor Swift Donates $50,000 to CHOP’s Cancer Center
Published on
A $50,000 gift from seven-time GRAMMY winner Taylor Swift will be used to create specialized programming for teens with cancer treated at CHOP’s Cancer Center.
Dr. Brodeur Receives Award for Neuroblastoma Research
Published on
The Advances in Neuroblastoma Research Association is conferring its highest honor on CHOP oncologist Garrett Brodeur, MD, for his scientific achievements.
Dr. Lange Honored for Career in Pediatric Leukemia
Published on
Beverly Lange, MD, a retired oncologist from The Children's Hospital of Philadelphia, was recognized for her lifetime of work with pediatric leukemia patients.
Broad Collaboration: The Childhood Brain Tumor Tissue Consortium
Published on
A growing bank of childhood brain tumor samples and associated clinical data, housed at CHOP, shows the great importance of collaborative efforts and sharing of data in pediatric cancer research.
Focused Science: BRAF Mutation-specific Approaches for Pediatric Brain Tumors
Published on
A new study by a brain tumor research team at CHOP supports the development of targeted treatment paradigms for BRAF-altered pediatric astrocytomas.
Brandon’s Pack of Lifesavers
Published on
Brandon was diagnosed with a rare brain tumor that wrapped around his brain stem. He found a team of lifesavers and hope for the future at The Children's Hospital of Philadelphia.
Exploring Kidney Disease in Cancer Survivors
Published on
Investigators in CHOP's Division of Nephrology are combining research with multidisciplinary clinics to improve kidney outcomes for children with cancer.
NBC Nightly News Features Results of Targeted Cellular Therapy for Leukemia
Published on
NBC’s Dr. Nancy Snyderman reports on results of a study on the effectiveness of a targeted cellular therapy for leukemia, CTL019.
Paradigms in Developmental Therapeutics: New Therapeutic Approaches and a New Way of Thinking
Published on
As new agents become more specific and target molecular characteristics of specific cancers, clinical trial enrollment may be restricted to children with relapsed cancers that harbor selected mutations.